RMCM
BEAM icon

Reynders McVeigh Capital Management’s Beam Therapeutics BEAM Stock Holding History

Reynders McVeigh Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,055
Closed -$201K – 199
2024
Q1 		$201K Buy
+6,055
New +$189K 0.01% 194
2023
Q3 		– Sell
-10,996
Closed -$351K – 195
2023
Q2 		$351K Sell
10,996
-46,560
-81% -$1.51M 0.02% 165
2023
Q1 		$1.76M Sell
57,556
-12,227
-18% -$483K 0.12% 74
2022
Q4 		$2.73M Sell
69,783
-5,131
-7% -$230K 0.2% 64
2022
Q3 		$3.57M Buy
74,914
+7,039
+10% +$402K 0.28% 56
2022
Q2 		$2.63M Sell
67,875
-15,389
-18% -$612K 0.2% 61
2022
Q1 		$4.77M Buy
83,264
+4,136
+5% +$271K 0.29% 51
2021
Q4 		$6.31M Buy
79,128
+6,330
+9% +$542K 0.36% 46
2021
Q3 		$6.33M Buy
72,798
+1,693
+2% +$170K 0.39% 46
2021
Q2 		$9.15M Buy
71,105
+3,653
+5% +$291K 0.56% 44
2021
Q1 		$5.4M Sell
67,452
-1,237
-2% -$118K 0.36% 46
2020
Q4 		$5.61M Buy
68,689
+9,828
+17% +$483K 0.38% 45
2020
Q3 		$1.45M Buy
+58,861
New +$1.46M 0.11% 83

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Reynders McVeigh Capital Management's BEAM Position: Q2 2024 in Review

Reynders McVeigh Capital Management sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 6,055 shares — an estimated $201K sold.

Reynders McVeigh Capital Management first reported a position in BEAM in Q3 2020 and held it in 13 quarters. The position peaked at $9.15M in Q2 2021. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • Reynders McVeigh Capital Management reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 6,055 Beam Therapeutics shares in Q2 2024, an estimated $201K.
  • Reynders McVeigh Capital Management first reported a position in Beam Therapeutics in Q3 2020 and held it in 13 quarters.
  • Reynders McVeigh Capital Management's Beam Therapeutics position peaked at $9.15M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.